JD Health International Inc. (Stock Code: 6618) has issued a proxy form outlining details for its extraordinary general meeting, scheduled for December 8, 2025, at Building C, Campus 2, No. 20 Kechuang 11 Street, BDA, Beijing. According to the announcement, four ordinary resolutions will be put forth, each concerning framework agreements between JD Health International Inc. and JD.com, Inc.
The resolutions pertain to the 2026 Technology and Traffic Support Services Framework Agreement, the 2026 JD Sales Framework Agreement (including transactions and annual caps up to the end of 2028), the 2026 Marketing Services Framework Agreement, and the 2026 Supply Chain Solutions and Logistics Services Framework Agreement. Shareholders are invited to vote on confirming, approving, and ratifying these agreements. Any one director of JD Health International Inc. will, upon approval of each resolution, be authorized to finalize the related transactions and documentation as specified in the published proxy form.